{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:38:50Z","timestamp":1792546730731,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Guizhou Province","award":["qiankehejichuQNA[2025]002"],"award-info":[{"award-number":["qiankehejichuQNA[2025]002"]}]},{"name":"the Excellent Young Talents Plan of Guizhou Province","award":["QKHPTRC-YQK[2023]029"],"award-info":[{"award-number":["QKHPTRC-YQK[2023]029"]}]},{"name":"Natural Science Research Foundation of Guizhou Provincial Department of Education","award":["qianjiaoji[2023]066"],"award-info":[{"award-number":["qianjiaoji[2023]066"]}]},{"name":"a grant from the State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine","award":["GMUSKL-202549"],"award-info":[{"award-number":["GMUSKL-202549"]}]},{"name":"the National Natural Science Foundation of China","award":["82560780"],"award-info":[{"award-number":["82560780"]}]},{"name":"Chinese Society of Traditional Chinese Medicine Youth Talent Lifting Project","award":["CACM-2024-(QNRC2-B42)"],"award-info":[{"award-number":["CACM-2024-(QNRC2-B42)"]}]},{"name":"Guizhou Province Science and Technology Support Program","award":["QKHZC-[2025]YB060"],"award-info":[{"award-number":["QKHZC-[2025]YB060"]}]},{"name":"the Guizhou Provincial Maior Scientific and Technological Program","award":["[2024]015"],"award-info":[{"award-number":["[2024]015"]}]},{"name":"the High-level Innovative Talents Fund of Guizhou Province","award":["GCC[2023]002"],"award-info":[{"award-number":["GCC[2023]002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04786-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:05:22Z","timestamp":1784894722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel inhalable tanshinone IIA lipid nanocrystal formulation for the enhanced treatment of idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Qin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"4786_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13287-022-03181-8","volume":"13","author":"Y Wenzhao Cheng","year":"2022","unstructured":"Wenzhao Cheng Y, Zeng, Wang D. Stem cell-based therapy for pulmonary fibrosis. Stem Cell Res Ther. 2022;13(1):492.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4786_CR2","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","volume":"15","author":"Q Xin Bai","year":"2024","unstructured":"Xin Bai Q, Chen F, Li Y, Teng M, Tang J, Huang X, Xu, Zhang X. Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy. Nat Commun. 2024;15(1):6844.","journal-title":"Nat Commun"},{"issue":"3","key":"4786_CR3","first-page":"273","volume":"12","author":"W Xiaoyan Xing","year":"2020","unstructured":"Xiaoyan Xing W, Qiang J, Bao R, Yang J, Hou K, Tao Z, Meng J, Zhang A, Zhang, Xiaobo Sun. Jinbei oral liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1\/Th2 shift. Chin Herb Med. 2020;12(3):273\u201380.","journal-title":"Chin Herb Med"},{"issue":"3","key":"4786_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.7150\/ijbs.90808","volume":"20","author":"L Jianzhi Wu","year":"2024","unstructured":"Jianzhi Wu L, Gong Y, Li T, Liu R, Sun K, Jia R, Liu F, Dong X, Gu, Li X. SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis. Int J Biol Sci. 2024;20(3):968\u201386.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4786_CR5","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.1038\/s41467-025-64211-6","volume":"16","author":"Q Suosi Liu","year":"2025","unstructured":"Suosi Liu Q, Wang J, Min Z, Zhang Y, Zhang J, Yang Y, Tan L, Tan M, Yin Y, Zhang X, Tang H, Peng Z, Xia. Yang Xiao, Zhiguang Zhou, Xia Li, and Shanshan Liu. The CCL20-integrin \u03b15\u03b21 interaction enhances TGF-\u03b2\/Smad signaling to promote fibroblast activation in pulmonary fibrosis. Nat Commun. 2025;16(1):9183.","journal-title":"Nat Commun"},{"issue":"1","key":"4786_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41392-025-02262-3","volume":"10","author":"M Li","year":"2025","unstructured":"Li M, Huang H, Wei X, Li H, Li J, Xie B, Yang Y, Fang X, Wang L, Zhang X, Wang H, Li M, Lin Y, Wang D, Wang Y, Zhao T. Jianqiu Sheng, Xinbao Hao, Muyang Yan, Lu Xu, and Zhijie Chang. Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment. Signal Transduct Target Ther. 2025;10(1):179.","journal-title":"Signal Transduct Target Ther"},{"issue":"28","key":"4786_CR7","doi-asserted-by":"publisher","first-page":"e2401327","DOI":"10.1002\/advs.202401327","volume":"11","author":"D Zheng","year":"2024","unstructured":"Zheng D, Guo J, Liang Z, Jin Y, Ding Y, Liu J, Qi C, Shi K, Xie L, Zhu M, Wang L, Yang ZHZ, Liu Q, Li X. Wen Ning, and Jie Gao. Supramolecular nanofibers ameliorate bleomycin-induced pulmonary fibrosis by restoring autophagy. Adv Sci. 2024;11(28):e2401327.","journal-title":"Adv Sci"},{"issue":"7","key":"4786_CR8","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.7150\/thno.54217","volume":"11","author":"J Hou","year":"2021","unstructured":"Hou J, Ji Q, Ji J, Ju S, Xu C, Yong X, Xu X, Muddassir M, Chen X, Xie J, Han X. Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy. Theranostics. 2021;11(7):3244\u201361.","journal-title":"Theranostics"},{"issue":"1","key":"4786_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41467-025-56501-w","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhou Y, Zhang W, Liu M, Duan J, Zhang X, Ma Q, Wang Y, Zhang Y, Guo Z. Ting Zhang, and Wei Zuo. Cloned airway basal progenitor cells to repair fibrotic lung through re-epithelialization. Nat commun. 2025;16(1):1303.","journal-title":"Nat commun"},{"key":"4786_CR10","doi-asserted-by":"publisher","first-page":"155997","DOI":"10.1016\/j.phymed.2024.155997","volume":"135","author":"Y Mengjie Jia","year":"2024","unstructured":"Mengjie Jia Y, Liu J, Liu J, Meng J, Cao L, Miao H, Zhang Y, Zhu. Mengmeng Sun, and Jian Yang. Xuanfei Baidu decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFN\u03b3\/STAT1\/STAT3 axis. Phytomedicine. 2024;135:155997.","journal-title":"Phytomedicine"},{"issue":"19","key":"4786_CR11","doi-asserted-by":"publisher","first-page":"e2405434","DOI":"10.1002\/advs.202405434","volume":"12","author":"D Shuo Liu, Kristen","year":"2025","unstructured":"Shuo Liu, Kristen D, Popowski CM, Eckhardt W, Zhang J, Li Y, Jing D, Silkstone E, Belcher. Megan Cislo, Shiqi Hu, Halle Lutz, Asma Ghodsi, Mengrui Liu, Phuong-Uyen C Dinh, and Ke Cheng. Inhalable Hsa-miR-30a-3p liposomes attenuate pulmonary fibrosis. Adv Sci. 2025;12(19):e2405434.","journal-title":"Adv Sci"},{"issue":"1","key":"4786_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12951-023-02251-0","volume":"22","author":"M Zheng","year":"2024","unstructured":"Zheng M, Liu K, Li L, Feng C, Wu G. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis. J Nanobiotechnol. 2024;22(1):14.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"4786_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/EXP.20240069","volume":"5","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhang Y, Zhang Q, Song P, Zhang J, Ma A, Wang C, Gao P, Yang T, Zhou L, Shi Q, Wong YK, Luo Y. Huan Tang, and Jigang Wang. Caffeic acid acts as a potent senomorphic and alleviates inflammation and lung fibrosis by covalently targeting annexin A5 protein in mice. Exploration. 2025;5(6):1\u201314.","journal-title":"Exploration"},{"issue":"9","key":"4786_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17512433.2024.2396121","volume":"17","author":"Y Katyayini Aribindi, Gabrielle","year":"2024","unstructured":"Katyayini Aribindi, Gabrielle Y, Liu, Timothy E, Albertson. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF). Expert Rev Clin Pharmacol. 2024;17(9):817\u201335.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"172","key":"4786_CR15","doi-asserted-by":"publisher","first-page":"240015","DOI":"10.1183\/16000617.0015-2024","volume":"33","author":"R Elizabeth","year":"2024","unstructured":"Elizabeth R, Volkmann CP, Denton M, Kolb, Marlies S, Wijsenbeek-Lourens C, Emson K, Hudson AJ, Amatucci O, Distler. Yannick Allanore, and Dinesh Khanna. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis. Eur Respir Rev. 2024;33(172):240015.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"4786_CR16","first-page":"251","volume":"15","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Xu X, Luo X, Liu R, Lin Y, Zhao P, Shi J. Preparation of tanshinone II(A) self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts. Chin Herb Med. 2023;15(2):251\u201362.","journal-title":"Chin Herb Med"},{"issue":"1","key":"4786_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12951-024-02407-6","volume":"22","author":"M Zheng","year":"2024","unstructured":"Zheng M, Zhu W, Gao F, Zhuo Y, Zheng M. Guanghao Wu, and Cuiling Feng. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects. J Nanobiotechnol. 2024;22(1):136.","journal-title":"J Nanobiotechnol"},{"issue":"48","key":"4786_CR18","doi-asserted-by":"publisher","first-page":"e10848","DOI":"10.1002\/adfm.202510848","volume":"35","author":"Z Feng Pan","year":"2025","unstructured":"Feng Pan Z, Guo B, Li Q, Zhang N, Liu Z, Wu Y, Liu X, Fei Y, Yang, Chen L. Inhalable lipid nanoparticles with mucus clearance and ROS scavenging properties for acute lung injury treatment. Adv Funct Mater. 2025;35(48):e10848.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"4786_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-bioeng-110122-010848","volume":"26","author":"R Ian","year":"2024","unstructured":"Ian R, Woodward, Catherine A, Fromen. Recent developments in aerosol pulmonary drug delivery: New technologies, new cargos, and new targets. Annu Rev Biomed Eng. 2024;26(1):307\u201330.","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"4786_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12951-023-01971-7","volume":"21","author":"Q Wan","year":"2023","unstructured":"Wan Q, Zhang X, Zhou D, Xie R, Cai Y, Zhang K, Sun X. Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects. J Nanobiotechnol. 2023;21(1):215.","journal-title":"J Nanobiotechnol"},{"key":"4786_CR21","doi-asserted-by":"publisher","first-page":"120418","DOI":"10.1016\/j.ijpharm.2021.120418","volume":"599","author":"H Liang","year":"2021","unstructured":"Liang H, Zou F, Liu Q, Wang B, Fu L, Liang X, Liu J, Liu Q. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy. Int J Pharm. 2021;599:120418.","journal-title":"Int J Pharm"},{"issue":"9","key":"4786_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/pharmaceutics16091155","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng X, Han X, Si J, Dong C, Ji Z, Zhao S, Wu X, Li H, Xiangqun Jin. Cationic curcumin nanocrystals liposomes for improved oral bioavailability: Formulation development, optimization, in vitro and in vivo evaluation. Pharmaceutics. 2024;16(9):1155.","journal-title":"Pharmaceutics"},{"issue":"6","key":"4786_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/nnm-2016-0405","volume":"12","author":"MK Gajanand Sharma","year":"2017","unstructured":"Gajanand Sharma MK, Saini K, Thakur N, Kapil NK, Garg K, Raza VG, Goni. Anil Pareek, and Om Prakash Katare. Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study. Nanomedicine. 2017;12(6):615\u201338.","journal-title":"Nanomedicine"},{"key":"4786_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2024.05.026","volume":"371","author":"Q Jianqing Peng","year":"2024","unstructured":"Jianqing Peng Q, Wang R, Sun K, Zhang Y, Chen, Gong Z. Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis. J Control Release. 2024;371:1\u201315.","journal-title":"J Control Release"},{"issue":"17","key":"4786_CR25","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1080\/07391102.2020.1801507","volume":"39","author":"T Priyanka Sharma","year":"2020","unstructured":"Priyanka Sharma T, Joshi T, Joshi S, Chandra, Tamta S. Molecular dynamics simulation for screening phytochemicals as \u03b1-amylase inhibitors from medicinal plants. J Biomol Struct Dyn. 2020;39(17):6524\u201338.","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"4786_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10953-019-00941-8","volume":"49","author":"T Xiaoxu Ba","year":"2020","unstructured":"Xiaoxu Ba T, Gao M, Yang P, Jiang F, Jiang, Liu Y. Thermodynamics of the interaction between graphene quantum dots with human serum albumin and \u03b3-globulins. J Solut Chem. 2020;49(1):100\u201316.","journal-title":"J Solut Chem"},{"issue":"88","key":"4786_CR27","doi-asserted-by":"publisher","first-page":"47649","DOI":"10.1039\/C4RA04616A","volume":"4","author":"Y Yuguang Song","year":"2014","unstructured":"Yuguang Song Y, Liu W, Liu FA, Villamena, Jay L, Zweier. Characterization of the binding of the finland trityl radical with bovine serum albumin. RSC Adv. 2014;4(88):47649\u201356.","journal-title":"RSC Adv"},{"issue":"5","key":"4786_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/17435390.2012.689880","volume":"7","author":"P Michaela Kendall","year":"2013","unstructured":"Michaela Kendall P, Ding R-M, Mackay R, Deb Z, McKenzie K, Kendall. Jens Madsen, and Howard Clark. Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology. 2013;7(5):963\u201373.","journal-title":"Nanotoxicology"},{"key":"4786_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.actbio.2022.05.038","volume":"147","author":"J Qiaoyu Liu","year":"2022","unstructured":"Qiaoyu Liu J, Xue X, Zhang J, Chai L, Qin J, Guan X, Zhang, Mao S. The influence of a biomimetic pulmonary surfactant modification on the in vivo fate of nanoparticles in the lung. Acta Biomater. 2022;147:391\u2013402.","journal-title":"Acta Biomater"},{"key":"4786_CR30","doi-asserted-by":"crossref","unstructured":"Zuojun Xu F, Ren P, Wang J, Cao C, Tan D, Ma L, Zhao J, Dai Y, Ding H, Fang H, Li H, Liu F, Luo Y, Meng P, Pan P, Xiang S, Liu Y, Lv H, Zhao. Shan Chen, Hui Cui, Mikhail Korzinkin, David Gennert, and Alex Zhavoronkov. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med. 2025;31 (8): 2602-10.","DOI":"10.1038\/s41591-025-03743-2"},{"issue":"5","key":"4786_CR31","doi-asserted-by":"publisher","first-page":"2100864","DOI":"10.1183\/13993003.00864-2021","volume":"59","author":"Z Shengren Song","year":"2022","unstructured":"Shengren Song Z, Fu R, Guan J, Zhao P, Yang Y, Li H, Yin Y, Lai G, Gong S, Zhao J, Yu X, Peng Y, He. Yumei Luo, Nanshan Zhong, and Jin Su. Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis. Eur Respir J. 2022;59(5):2100864.","journal-title":"Eur Respir J"},{"issue":"6","key":"4786_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7150\/ijms.8365","volume":"11","author":"H Wu","year":"2014","unstructured":"Wu H, Li Y, Wang Y, Xu D, Li C, Liu M, Xin Sunand, Li Z. Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2\/ angiotensin-(1\u20137) axis in rats. Int J Med Sci. 2014;11(6):578\u201386.","journal-title":"Int J Med Sci"},{"issue":"2","key":"4786_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s11095-014-1491-3","volume":"32","author":"P Liu","year":"2015","unstructured":"Liu P, Viitala T, Kartal-Hodzic A, Liang H, Laaksonen T. Jouni Hirvonen, and Leena Peltonen. Interaction studies between indomethacin nanocrystals and PEO\/PPO copolymer stabilizers. Pharm Res. 2015;32(2):628\u201339.","journal-title":"Pharm Res"},{"key":"4786_CR34","unstructured":"Teymouri Rad R, Mortazavi SA, Vatanara A, Dadashzadeh S. Enhanced Dissolution Rate of Tadalafil Nanoparticles Prepared by Sonoprecipitation Technique: Optimization and Physicochemical Investigation. Iran J Pharm Res. 2017;16(4):1335-1348."},{"key":"4786_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcis.2016.10.055","volume":"488","author":"IE K\u0142osowska-Chomiczewska","year":"2017","unstructured":"K\u0142osowska-Chomiczewska IE, M\u0119drzycka K, Hallmann E, Karpenko E, Pokynbroda T, Macierzanka A, Jungnickel C. Rhamnolipid CMC prediction. J Colloid Interface Sci. 2017;488:10\u20139.","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"4786_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/pharmaceutics8020016","volume":"8","author":"J Annika Tuomela","year":"2016","unstructured":"Annika Tuomela J, Hirvonen, Peltonen L. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharmaceutics. 2016;8(2):16.","journal-title":"Pharmaceutics"},{"key":"4786_CR37","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.jddst.2023.104351","volume":"83","author":"Y Ziyue Xi","year":"2023","unstructured":"Ziyue Xi Y, Fei Y, Wang Q, Lin Q, Ke GF, Xu L. Solubility improvement of curcumin by crystallization inhibition from polymeric surfactants in amorphous solid dispersions. J Drug Deliv Sci Technol. 2023;83:104351.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"4786_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.colsurfb.2011.04.033","volume":"87","author":"E Filipe","year":"2011","unstructured":"Filipe E, Antunes L, Gentile CO, Rossi. Lorena Tavano, and Giuseppe Antonio Ranieri. Gels of pluronic F127 and nonionic surfactants from rheological characterization to controlled drug permeation. Colloids Surf B Biointerfaces. 2011;87(1):42\u201348.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"4786_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(97)00419-5","volume":"162","author":"E Am\u00e9lie Bochot","year":"1998","unstructured":"Am\u00e9lie Bochot E, Fattal JL, Grossiord F, Puisieux, Couvreur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int J Pharm. 1998;162(1):119\u201327.","journal-title":"Int J Pharm"},{"issue":"1","key":"4786_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/medicines6010007","volume":"6","author":"D Elena Giuliano","year":"2018","unstructured":"Elena Giuliano D, Paolino M, Fresta, Cosco D. Drug-loaded biocompatible nanocarriers embedded in poloxamer 407 hydrogels as therapeutic formulations. Medicines. 2018;6(1):7.","journal-title":"Medicines"},{"key":"4786_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-cellbio-100617-062818","volume":"34","author":"CE Wagner","year":"2018","unstructured":"Wagner CE, Wheeler KM, Ribbeck K. Mucins and their role in shaping the functions of mucus barriers. Annu Rev Cell Dev Biol. 2018;34:189\u2013215.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"10","key":"4786_CR42","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1152\/ajplung.00046.2016","volume":"310","author":"S Caroline Ridley","year":"2016","unstructured":"Caroline Ridley S, Kirkham, Sally J, Williamson CW, Davis P, Woodman, David J, Thornton. Biosynthesis of the polymeric gel-forming mucin MUC5B. Am J Physiol Lung Cell Mol Physiol. 2016;310(10):993\u20131002.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4786_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","volume":"70","author":"J David","year":"2008","unstructured":"David J, Thornton K, Rousseau, Michael AMG. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459\u201386.","journal-title":"Annu Rev Physiol"},{"key":"4786_CR44","doi-asserted-by":"publisher","first-page":"114309","DOI":"10.1016\/j.addr.2022.114309","volume":"185","author":"W Wang","year":"2022","unstructured":"Wang W, Huang Z, Huang Y, Zhang X, Huang J, Cui Y, Yue X, Ma C, Fu F, Wang W. Chuanbin Wu, and Xin Pan. Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches. Adv Drug Deliv Rev. 2022;185:114309.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4786_CR45","doi-asserted-by":"publisher","first-page":"130839","DOI":"10.1016\/j.ijbiomac.2024.130839","volume":"265","author":"J Peng","year":"2024","unstructured":"Peng J, Zhang X, Zhang K, Wang Q, Sun R, Chen Y, Chen Y, Gong Z. Polysaccharides screening for pulmonary mucus penetration by molecular dynamics simulation and in vitro verification. Int J Biol Macromol. 2024;265(2):130839.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4786_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jth.13623","volume":"15","author":"C Lin","year":"2017","unstructured":"Lin C, Borensztajn K, Spek CA. Targeting coagulation factor receptors \u2013 protease-activated receptors in idiopathic pulmonary fibrosis. J Thromb Haemost. 2017;15(4):597\u2013607.","journal-title":"J Thromb Haemost"},{"key":"4786_CR47","doi-asserted-by":"publisher","first-page":"115244","DOI":"10.1016\/j.intimp.2025.115244","volume":"163","author":"Y Xue Gao","year":"2025","unstructured":"Xue Gao Y, Chen S, Wu Z, Deng X, Wei G, Zhang Y, Zhao, Qian J. SZ168 alleviates bleomycin-induced pulmonary fibrosis by inhibiting podoplanin-induced platelet activation. Int Immunopharmacol. 2025;163:115244.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4786_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/thoraxjnl-2013-204367","volume":"69","author":"J Ricardo","year":"2014","unstructured":"Ricardo J, Jos\u00e9 AE, Williams, Rachel C, Chambers. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69(2):190\u20132.","journal-title":"Thorax"},{"issue":"1","key":"4786_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"W Jincheng","year":"2022","unstructured":"Jincheng W, Cai KHX, Yang B, He Q, Wang J, Weng Q. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 2022;12(1):18\u201332.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"4786_CR50","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1164\/rccm.201009-1479OC","volume":"183","author":"GKM Wygrecka","year":"2011","unstructured":"Wygrecka GKM, Jablonska E, von Gerlach S, Henneke I, Zakrzewicz D, Guenther A, Klaus T, Preissner, Philipp Markart. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(12):1703\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"4786_CR51","doi-asserted-by":"publisher","first-page":"111475","DOI":"10.1016\/j.biopha.2021.111475","volume":"138","author":"T Zhang","year":"2021","unstructured":"Zhang T, Liu M, Gao Y, Li H, Song L, Hou H, Chen T, Ma L, Zhang G, Ye Z. Salvianolic acid B inhalation solution enhances antifibrotic and anticoagulant effects in a rat model of pulmonary fibrosis. Biomed Pharmacother. 2021;138:111475.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04786-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:03:23Z","timestamp":1792544603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04786-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04786-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"970"}}